Antibiotics Under Siege

Governments are failing to prioritize the development of new antibiotics, leading to a troubling gap in our ability to combat bacterial infections. As drug makers shift focus to more profitable treatments, bacteria exploit their evolutionary advantages, rapidly developing resistance to existing antibiotics. This misuse and overuse of antibiotics in various sectors only exacerbates the crisis, making once-treatable infections increasingly difficult to manage.